Literature DB >> 6928631

Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.

G Poste, G L Nicolson.   

Abstract

B16 mouse melanoma sublines in culture spontaneously shed intact plasma membrane vesicles. These vesicles can be fused with the plasma membrane of cells from homologous and heterologous B16 sublines by using polyethylene glycol and phytohemagglutinin-P. Fusion of vesicles from a highly metastatic subline (F10) that localizes exclusively in the lung with cells from a poorly metastatic subline (F1) significantly increased the ability of F1 cells to become arrested in the lung and form metastases in this organ. In contrast, fusion of F1 vesicles with F10 cells did not alter the ability of vesicle-modified cells to localize in the lung or form lung metastases. F10 vesicle-modified F1 cells reverted to their original arrest behavior and metastatic capacity after removal of F10 vesicle components from the plasma membrane. The changes in the arrest and metastatic behavior of F10 vesicle-modified F1 cells were highly highly specific. Vesicles from other B16 sublines that are poorly metastatic and show limited localization in the lung (F1, FLLr, and F10Lr) did not modify the arrest behavior and metastatic capacity of FU cells. These results suggest that the differences in the abilities of the F1 and F10 sublines to localize in the lung are determined by differences in cell surface properties.

Entities:  

Mesh:

Year:  1980        PMID: 6928631      PMCID: PMC348278          DOI: 10.1073/pnas.77.1.399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion.

Authors:  R H Kramer; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Phytohemagglutinin enhancement of cell fusion reduces polyethylene glycol cytotoxicity.

Authors:  W E Mercer; R A Schlegel
Journal:  Exp Cell Res       Date:  1979-05       Impact factor: 3.905

3.  Organ selectivity in human cancer metastasis. A review.

Authors:  W I Onuigbo
Journal:  Oncology       Date:  1974       Impact factor: 2.935

4.  An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures.

Authors:  G P Studzinski; J F Gierthy; J J Cholon
Journal:  In Vitro       Date:  1973 May-Jun

5.  Inability of choleragenoid-sensitized cells to induce T cell-mediated cytolysis.

Authors:  J Forman; R A Finkelstein
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

6.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

7.  Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.

Authors:  A Raz; R Barzilai; G Spira; M Inbar
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

8.  Transplantable metastasizing prostate adenocarcinomas in rats.

Authors:  M Pollard; P H Luckert
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

9.  Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.

Authors:  I J Fidler; D M Gersten; M B Budmen
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

10.  Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanisms.

Authors:  M Petitou; F Tuy; C Rosenfeld; Z Mishal; M Paintrand; C Jasnin; G Mathe; M Inbar
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

View more
  72 in total

1.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.

Authors:  Giulia Taraboletti; Sandra D'Ascenzo; Patrizia Borsotti; Raffaella Giavazzi; Antonio Pavan; Vincenza Dolo
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

2.  Cancer: Organ-seeking vesicles.

Authors:  Janusz Rak
Journal:  Nature       Date:  2015-10-28       Impact factor: 49.962

Review 3.  Microvesicles: mediators of extracellular communication during cancer progression.

Authors:  Vandhana Muralidharan-Chari; James W Clancy; Alanna Sedgwick; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2010-05-15       Impact factor: 5.285

4.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.

Authors:  Edward Allan Racela Sison; Peter Kurre; Yong-Mi Kim
Journal:  Pediatr Hematol Oncol       Date:  2017-12-06       Impact factor: 1.969

Review 6.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Monoclonal antibodies inhibit the adhesion of mouse B 16 melanoma cells in vitro and block lung metastasis in vivo.

Authors:  H P Vollmers; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Decreased tumorigenicity correlates with expression of altered cell surface carbohydrates in Lec9 CHO cells.

Authors:  J Ripka; S Shin; P Stanley
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

9.  An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines.

Authors:  Salvatrice Rigogliuso; Chiara Donati; Donata Cassarà; Simona Taverna; Monica Salamone; Paola Bruni; Maria Letizia Vittorelli
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

10.  Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.

Authors:  M Ueda; Y Mishima; M Mojamdar; M Ichihashi; M Kita; T Kishida
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.